Johnson & Johnson (NYSE:JNJ) completes the sale of its Codman Neurosurgery unit to Integra LifeSciences Holding (NASDAQ:IART) for $1.045B.
Previously: Integra to buy J&J's Codman Neurosurgery unit for $1.045B(Feb. 15)
READ FULL ARTICLE HERE
Johnson & Johnson (NYSE:JNJ) completes the sale of its Codman Neurosurgery unit to Integra LifeSciences Holding (NASDAQ:IART) for $1.045B.
Previously: Integra to buy J&J's Codman Neurosurgery unit for $1.045B(Feb. 15)
READ FULL ARTICLE HERE